glp 1 ckd Potential kidney-protective and other effects of GLP-1 receptor Taking the next step: the

The pharmacokinetic differences between these drugs lead to important differences in their pharmacodynamic profiles

Their surging popularity has also revealed critical vulnerabilities in affordability and access

Although reported AEs are generally not serious and safety and efficacy in older adults are generally comparable to those in younger adults [36], higher AE rates may nonetheless predispose older adults to additional risks that are more critical in this population, such as hypoglycemia, dehydration, or impaired renal function

Exploring this idea, Glers team used a new type of GLP-1 drug that can be taken orally and is composed of much smaller molecules, making it easier to cross the blood-brain barrier

A., Rajasekeran, H., Lytvyn, Y., Lovblom, L